Dyne Therapeutics, Inc. Balance Sheet
DYN / Health Care|6 years of annual SEC 10-K data (FY2019-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 6 fiscal years. All figures from audited SEC 10-K filings.
Dyne Therapeutics, Inc. had $691M in total assets and $630M in shareholders' equity as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $435.4M | $121.6M | $172.1M | $200.8M | $300.9M | $14.6M |
| Current Assets | $659.3M | $129.4M | $265.6M | $382.4M | $349.1M | $14.8M |
| PP&E (Net) | $5.4M | $4.8M | $5.9M | $4.7M | $1.9M | $1.5M |
| Total Assets | $691.2M | $165.1M | $306.3M | $425.7M | $353.3M | $16.4M |
| Current Liabilities | $42.3M | $51.1M | $28.1M | $28.7M | $11.0M | $2.4M |
| Shareholders' Equity | $629.8M | $91.3M | $252.4M | $368.2M | $342.4M | $14.0M |